Clinical Lymphoma Myeloma & Leukemia Journal Citation Rate 2026
2152-2650
eISSN 2152-2669
Elsevier BV
US
Q3 Quartile
About Clinical Lymphoma Myeloma & Leukemia
Clinical Lymphoma Myeloma & Leukemia (CLML) is a peer-reviewed academic journal, published by Elsevier BV in US, catalogued under ISSN 2152-2650 (e-ISSN 2152-2669). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 0.28 (Q3 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$3670 USD).
Clinical Lymphoma Myeloma & Leukemia Citation Rate 2026 — In Context
Clinical Lymphoma Myeloma & Leukemia has a 2025 2-Year Citation Rate (OpenAlex) of 0.28, placing it in the Q3 quartile. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Clinical Lymphoma Myeloma & Leukemia operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Clinical Lymphoma Myeloma & Leukemia should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Clinical Lymphoma Myeloma & Leukemia against similar journals in the field, use our journal comparison tool.
Submission Tips for Clinical Lymphoma Myeloma & Leukemia
- Budget $3670 for the Article Processing Charge. Check if your institution or funder covers OA fees.
| ISSN (Print) | 2152-2650 |
|---|---|
| ISSN (Online) | 2152-2669 |
| Publisher | Elsevier BV |
| Country | United States |
| APC / Cost | $3670 USD |
In-depth profile & metrics
Clinical Lymphoma Myeloma & Leukemia is published by Elsevier BV and based in United States. It runs on a subscription or hybrid model with an article-processing charge of USD 3670.
Clinical Lymphoma Myeloma & Leukemia is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 0.281.
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Clinical Lymphoma Myeloma & Leukemia
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 0.281 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S186546955
Get weekly updates
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.